Insider Transactions Reported by 11 Insiders of Jaguar Health, Inc.

Symbol
JAGX on Nasdaq
Location
San Francisco, CA

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

Jaguar Health, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Lisa A. Conte Chief Exec. Officer & President, Director $473,128,965 11 Dec 2025
Jonathan B. Siegel Director $473,112,619 11 Dec 2025
Jonathan S. Wolin Chief of Staff, Chief Compliance Officer & General Counsel $473,111,818 11 Dec 2025
John Micek Director $473,104,383 11 Dec 2025
Pravin R. Chaturvedi Chief Scientific Officer $75,720,294 11 Dec 2025
Lincoln Alternative Strategies LLC 10%+ Owner $1,284,000 28 Aug 2025
Steven R. King Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary $87,466 11 Dec 2025
Carol R. Lizak Chief Financial Officer $20,248 11 Dec 2025
James J. Bochnowski Director $10,905 11 Dec 2025
Anula Jayasuriya Director $10,057 11 Dec 2025
Gregory J. Divis Director $364 18 May 2022

Recent Insider Transactions by Companies or Individuals for Jaguar Health, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
John Micek JAGX Common Stock Award 13918.9% 7,377 7,430 11 Dec 2025 Direct
John Micek JAGX Stock Option (right to buy) Award 7,377 7,377 11 Dec 2025 Direct
Steven R. King JAGX Common Stock Award 8096.6% 11,740 11,885 11 Dec 2025 Direct
Steven R. King JAGX Stock Option (right to buy) Award 11,740 11,740 11 Dec 2025 Direct
Lisa A. Conte JAGX Common Stock Award 4293.1% 28,592 29,258 11 Dec 2025 Direct
Lisa A. Conte JAGX Stock Option (right to buy) Award 28,592 28,592 11 Dec 2025 Direct
Jonathan S. Wolin JAGX Common Stock Award 5929.3% 11,740 11,938 11 Dec 2025 Direct
Jonathan S. Wolin JAGX Stock Option (right to buy) Award 11,740 11,740 11 Dec 2025 Direct
Pravin R. Chaturvedi JAGX Common Stock Award 5929.3% 11,740 11,938 11 Dec 2025 Direct
Pravin R. Chaturvedi JAGX Stock Option (right to buy) Award 11,740 11,740 11 Dec 2025 Direct
James J. Bochnowski JAGX Common Stock Award 12236.5% 6,363 6,415 11 Dec 2025 Direct
James J. Bochnowski JAGX Stock Option (right to buy) Award 6,363 6,363 11 Dec 2025 Direct
Jonathan B. Siegel JAGX Common Stock Award 16037% 7,377 7,423 11 Dec 2025 Direct
Jonathan B. Siegel JAGX Stock Option (right to buy) Award 7,377 7,377 11 Dec 2025 Direct
Anula Jayasuriya JAGX Common Stock Award 12760.9% 5,870 5,916 11 Dec 2025 Direct
Anula Jayasuriya JAGX Stock Option (right to buy) Award 5,870 5,870 11 Dec 2025 Direct
Carol R. Lizak JAGX Common Stock Award 6865.5% 11,740 11,911 11 Dec 2025 Direct
Carol R. Lizak JAGX Stock Option (right to buy) Award 11,740 11,740 11 Dec 2025 Direct
Jonathan B. Siegel JAGX Warrant to Purchase Common Stock Award 18,262 9,000 24 Jun 2025 See footnote
Jonathan B. Siegel JAGX Convertible Promissory Note Award 9,462 9,462 24 Jun 2025 See footnote
Jonathan B. Siegel JAGX Convertible Promissory Note Disposed to Issuer -100% -9,000 0 24 Jun 2025 See footnote
John Micek JAGX Warrant to Purchase Common Stock Award 18,262 9,000 24 Jun 2025 Direct
John Micek JAGX Convertible Promissory Note Award 9,462 9,462 24 Jun 2025 Direct
John Micek JAGX Convertible Promissory Note Disposed to Issuer -100% -9,000 0 24 Jun 2025 Direct
James J. Bochnowski JAGX Warrant to Purchase Common Stock Award 54,786 27,002 24 Jun 2025 See footnote
James J. Bochnowski JAGX Convertible Promissory Note Award 28,388 28,388 24 Jun 2025 See footnote
James J. Bochnowski JAGX Convertible Promissory Note Disposed to Issuer -100% -27,002 0 24 Jun 2025 See footnote
Steven R. King JAGX Warrant to Purchase Common Stock Award 7,304 3,600 24 Jun 2025 Direct
Steven R. King JAGX Convertible Promissory Note Award 3,785 3,785 24 Jun 2025 Direct
Steven R. King JAGX Convertible Promissory Note Disposed to Issuer -100% -3,600 0 24 Jun 2025 Direct
Pravin R. Chaturvedi JAGX Warrant to Purchase Common Stock Award 7,304 3,600 24 Jun 2025 Direct
Pravin R. Chaturvedi JAGX Convertible Promissory Note Award 3,785 3,785 24 Jun 2025 Direct
Pravin R. Chaturvedi JAGX Convertible Promissory Note Disposed to Issuer -100% -3,600 0 24 Jun 2025 Direct
Jonathan S. Wolin JAGX Warrant to Purchase Common Stock Award 18,262 9,000 24 Jun 2025 Direct
Jonathan S. Wolin JAGX Convertible Promissory Note Award 9,462 9,462 24 Jun 2025 Direct
Jonathan S. Wolin JAGX Convertible Promissory Note Disposed to Issuer -100% -9,000 0 24 Jun 2025 Direct
Lisa A. Conte JAGX Warrant to Purchase Common Stock Award 18,262 9,000 24 Jun 2025 Direct
Lisa A. Conte JAGX Convertible Promissory Note Award 9,462 9,462 24 Jun 2025 Direct
Lisa A. Conte JAGX Convertible Promissory Note Disposed to Issuer -100% -9,000 0 24 Jun 2025 Direct
Steven R. King JAGX Common Stock Options Exercise 0.69% 1 145 17 May 2025 Direct
Steven R. King JAGX Restricted stock units Options Exercise -100% -1 0 17 May 2025 Direct
Lisa A. Conte JAGX Common Stock Options Exercise 0.3% 2 666 17 May 2025 Direct
Lisa A. Conte JAGX Restricted stock units Options Exercise -100% -2 0 17 May 2025 Direct
John Micek JAGX Warrant to Purchase Common Stock Purchase 9,000 9,000 31 Mar 2025 Direct
John Micek JAGX Convertible Promissory Note Purchase 9,000 9,000 31 Mar 2025 Direct
Steven R. King JAGX Warrant to Purchase Common Stock Purchase 3,600 3,600 31 Mar 2025 Direct
Steven R. King JAGX Convertible Promissory Note Purchase 3,600 3,600 31 Mar 2025 Direct
Jonathan B. Siegel JAGX Warrant to Purchase Common Stock Purchase 9,000 9,000 31 Mar 2025 See Footnote
Jonathan B. Siegel JAGX Convertible Promissory Note Purchase 9,000 9,000 31 Mar 2025 See Footnote
Lisa A. Conte JAGX Warrant to Purchase Common Stock Purchase 9,000 9,000 31 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.